Neurogastrx

About:

A private biopharmaceutical company .

Top Investors: Propel(X), OrbiMed, RTW Investments, Samsara BioCapital, Marshall Wace

Description:

Neurogastrx, Inc. is a venture-stage biopharmaceutical company developing products for the treatment of gastrointestinal disorders.

Total Funding Amount:

$105M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Woburn, Massachusetts, United States

Founded Date:

2012-01-01

Contact Email:

info(AT)neurogastrx.com

Founders:

Cyril De Colle, Jim O’Mara

Number of Employees:

11-50

Last Funding Date:

2021-08-26

IPO Status:

Private

Industries: